Records containing: HIV Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-08-17See Detailed Description
-
CLINICAL_TRIALS study record update · 2011-08-15Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers in Zambia: Piloting a Household Water Treatment Intervention
-
CLINICAL_TRIALS study record update · 2011-08-11An Evaluation of Integration of Family Planning Into HIV/AIDS Care and Treatment Clinics in Tanzania
-
CLINICAL_TRIALS study record update · 2011-08-08A Multicenter, Open Label, Non-Comparative Safety Study Of Maraviroc
-
CLINICAL_TRIALS study record update · 2011-07-27Short Duration Exclusive Breastfeeding With Abrupt Weaning to Reduce the Risk of Mother-to-Child HIV Transmission
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-07-27HIV Treatment and CVD Events - Ingenix. Retrospective Database Analysis of Patients With Human Immunodeficiency Virus (HIV) Treatment and Cardiovascular Disease (CVD) Events
-
CLINICAL_TRIALS study record update · 2011-06-23A Phase I, Open Label, Controlled, Intra-subject Comparison Study to Investigate the Effect of Co-administration Upon the Pharmacokinetics of Tipranavir (Ritonavir Boosted) and Apricitabine.
-
CLINICAL_TRIALS study record update · 2011-06-23An Open Label Long Term Safety Extension Study of Apricitabine in Treatment-experienced HIV-1 Infected Subjects
-
CLINICAL_TRIALS study record update · 2011-06-08A Phase II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Biological Activity of Single and Repeated Doses of Autologous T Cells Transduced With VRX496 in HIV-Positive Subjects
-
CLINICAL_TRIALS study record update · 2011-06-08Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected Patients
-
CLINICAL_TRIALS study record update · 2011-05-19HIV-1 Infected Subjects Who Were Randomized in Any Sponsor-selected TMC125 Trial to an Active Control Arm and Either Virologically Failed or Completed the Entire Treatment Period, or to Placebo Arm and Were Treated for at Least 48 Weeks.
-
CLINICAL_TRIALS study record update · 2011-05-19A Phase II, Randomized, Active Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-na�ve and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use.
-
CLINICAL_TRIALS study record update · 2011-05-16A Phase Iv Single-Arm Open-Label Non-Randomized Study To Evaluate The Safety And Pharmacokinetics Of Nelfinavir (Viracept, A430) 1250mg Twice Daily (250mg Or 625mg Forms) With Lamivudine/Zidovudine (Combivir) Background Therapy In Hiv/Hepatitis C Virus (Hcv) Co-Infected Subjects With Hepatic Dysfunction.
-
CLINICAL_TRIALS study record update · 2011-05-16See Detailed Description
-
CLINICAL_TRIALS study record update · 2011-04-28A Phase IV, Non-Randomized, Open-Label Trial Evaluating The Safety Of 625 mg Formulation Of VIRACEPT When Administered To HIV-Infected Women During Pregnancy
-
CLINICAL_TRIALS study record update · 2011-04-14Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight
-
CLINICAL_TRIALS study record update · 2011-04-13An Exploratory Study of the Effect of the Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response
-
CLINICAL_TRIALS study record update · 2011-04-07A Study of the Pharmacokinetics of Atazanavir (ATV)/Ritonavir(RTV) Administered as Part of Highly Active Antiretroviral Therapy (HAART) in HIV-1 Infected Pregnant Women
-
CLINICAL_TRIALS study record update · 2011-03-29A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Compare the Efficacy and Safety of GW873140 400mg BID in Combination With a Ritonavir-containing Optimized Background Therapy (OBT) Regimen Versus Placebo Plus OBT Over 48 Weeks.
-
CLINICAL_TRIALS study record update · 2011-03-29A Screening Protocol to Determine Eligibility for One of Three Phase III Treatment Studies Evaluating the Efficacy and Safety of GW873140 in R5-tropic and R5/X4-tropic HIV-1 Infected, Treatment-experienced Subjects With Drug-resistant Virus or an Observational Study.
-
CLINICAL_TRIALS study record update · 2011-03-07A Phase IIb, Multi-centre, Randomised, Double-blind, Active-controlled Trial Comparing the Neuropsychiatric Adverse Event Profile of Etravirine 400mg qd Versus Efavirenz 600mg qd in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in ARV Therapy-naive HIV-1 Infected Subjects
-
CLINICAL_TRIALS study record update · 2011-03-01Observational Study of the Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat in Hiv-1 Infected Adult Volunteers
-
CLINICAL_TRIALS study record update · 2011-02-23ClinicalTrials.gov study NCT01300689
-
CLINICAL_TRIALS study record update · 2011-02-03Open-Label, Randomized Controlled Trial Comparing Three Strategies of Hepatitis B Vaccination in HIV-1-Infected Patients With CD4 Cell Counts Above 200 permm3 and Suppressed Viral Load
-
CLINICAL_TRIALS study record update · 2010-12-13A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients With Low CD4+ Counts Under Active Antiretroviral Therapy (SILCAAT Amendment 4)